Business Wire

Backlight to Showcase Product Line Innovations Across Creative and Streaming Workflows at IBC 2023

7.9.2023 18:50:00 EEST | Business Wire | Press release

Share

Global media and entertainment technology company Backlight announced that it is returning to the International Broadcasting Convention (IBC) this month with many new product updates and integrations to share with the industry. Backlight will be at booth 1.D09 to showcase innovative solutions that improve the video content lifecycle for broadcasters, content creators, publishers and distributors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230907741048/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Global media and entertainment technology company Backlight will showcase its feature-rich solutions that reduce pain points across the video lifecycle for more streamlined production and monetization at the 2023 International Broadcasting Convention (IBC). (Graphic: Business Wire)

Request a meeting with Backlight at IBC here.

Backlight Product Updates and Integrations

Backlight’s feature-rich solutions allow broadcasters and rights owners to create more content, distribute everywhere, unlock new revenue streams, and manage media and creative projects in the cloud intelligently and economically. The latest updates to its products to reduce pain points across the video lifecycle for more streamlined production and monetization include:

  • Wildmoka Live Studio: Backlight’s new digital-first live production platform. Backlight will demonstrate how Live Studio’s single interface makes it easy to tailor an existing live stream, or create a new one, from multiple live sources, clips, graphics and images, while preserving brand consistency with pre-configured production rooms and templated destinations. With the browser-based Live Studio, customers quickly generate platform-specific, low-latency content experiences and engage broader audiences through simultaneous distribution to any digital destination.
  • AI-assisted inventory creation within Zype Playout. Backlight’s ability to detect ad opportunities using machine learning is combined with low latency ad routing, device targeting, and a custom approach to ad macros in the newest version of Zype Playout. Customers have seen 516% increases in ad inventory, 15% increases in fill rate and 44% improvements in ad rendering when compared to leading playout providers.
  • Asset management, cloud production and content distribution – simplified. Backlight will showcase how easy it is to pull assets from any storage managed by iconik into Wildmoka’s live production environment for hyperdistribution as well as workflows for metadata-intelligent live-to-archive.
    • Add media management, review and collaboration to live media management workflows and scale up in the cloud for key events.
    • Push clips or archived content from Wildmoka to iconik for long-term storage, quick discovery, and reutilization in marketing initiatives – all in a browser.
  • New features and integrations for iconik, ftrack and cineSync increase creative workflow speed, flexibility and control.
    • iconik’s Favoriting functionality allows quicker retrieval of key assets, and updates to Collections now provide detailed insights into their sizes and creation history to empower better storage decision-making and resource allocation.
    • iconik demos will include a forthcoming integration with Apple's Final Cut Pro X that empowers users to effortlessly import/export iconik media directly into their FCPX editing environment and an updated integration with the powerful media review and approval solution cineSync.
    • cineSync expands format and standards support with OTIOZ playback, USD support and new ways to manage colors and notes in cineSync 5
    • ftrack Studio offers next-level precision for creative reviews by adding Wacom and stylus support and increased control for production tracking with new task scheduling and notification options.

Backlight’s Leaders to Share Insights on Monetizing Content and Remote Production

Leaders from Backlight will participate in two thought leadership forums at IBC—the SVG Sport Production Summit and the DPP Espresso Summit:

SVG Europe Sport Production Summit | Thursday, September 14, 2023 at 15:05 CET

  • Christophe Messa, Backlight’s director of Strategic Partners will join panelists from Tinkerlist, Spiideo, and Vislink for a discussion on Making and Monetizing Sports Content at the SVG Europe Sports Production Summit. Attendees will learn about best practices and new strategies that right owners are using to generate income for sports content, including on social media, OTT platforms and apps.

DPP Espresso Summit | Friday, September 15, 2023 at 0930 CET

  • At this breakfast briefing hosted by DPP, Backlight Chief Product Officer, Mike Szumlinski and other panelists will discuss hybrid working and the technology needed to support remote production more broadly.

Backlight is Shortlisted for Three Awards at IBC

  • The International Trade Association for the Broadcast & Media Industry (IABM) has shortlisted Backlight’s media management platform, iconik, for a BaM award in the Manage category. Iconik revolutionizes how organizations of all sizes manage, share and collaborate on digital assets.
  • Backlight’s Zype Apps Creator solution was shortlisted for an award by CSI Magazine in the Best VoD or content-on-demand solution category. Zype Apps Creator is Backlight’s turnkey solution for building streaming apps to deliver and monetize branded experiences across owned and operated and popular third-party platforms.
  • Backlight has been shortlisted for a Corporate Star award for Best Charity/CSR initiative for its collaboration with HUFO, a student-led film organization at Howard University that provides students with the resources they need to launch and leverage careers within the entertainment industry.

About Backlight

Backlight is a global media technology company that dramatically improves every stage of the video and entertainment content lifecycle, from creation through monetization. Backed by $200M in funding from PSG, Backlight has acquired six leading media software companies since launching in 2021. Video-forward organizations solve their mission-critical business and operational challenges by partnering with Backlight’s two divisions: Backlight Creative and Backlight Streaming. Backlight Creative provides award-winning software solutions for secure and efficient media management, production tracking and creative collaboration, including iconik, ftrack, Gem and Celtx. Backlight Streaming provides cloud-based OTT video streaming, content management, media production, hyperdistribution, and monetization software, including Zype and Wildmoka, to the world’s most innovative publishers and broadcasters. For more information visit backlight.co.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Bubble Agency for Backlight | backlight@bubbleagency.com
Backlight | media@backlight.co

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye